DK475389A - Fremgangsmaade til reduktion af monoklonale antistoffers heterogenitet - Google Patents
Fremgangsmaade til reduktion af monoklonale antistoffers heterogenitet Download PDFInfo
- Publication number
- DK475389A DK475389A DK475389A DK475389A DK475389A DK 475389 A DK475389 A DK 475389A DK 475389 A DK475389 A DK 475389A DK 475389 A DK475389 A DK 475389A DK 475389 A DK475389 A DK 475389A
- Authority
- DK
- Denmark
- Prior art keywords
- monoclonal antibodies
- reducing heterogeneity
- heterogeneity
- reducing
- monoclonal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25078788A | 1988-09-28 | 1988-09-28 | |
US25078888A | 1988-09-28 | 1988-09-28 | |
US25078688A | 1988-09-28 | 1988-09-28 | |
US07/364,056 US5126250A (en) | 1988-09-28 | 1989-06-09 | Method for the reduction of heterogeneity of monoclonal antibodies |
CA000613379A CA1332367C (en) | 1988-09-28 | 1989-09-26 | Method for the reduction of heterogeneity of monoclonal antibodies |
Publications (2)
Publication Number | Publication Date |
---|---|
DK475389D0 DK475389D0 (da) | 1989-09-27 |
DK475389A true DK475389A (da) | 1990-03-29 |
Family
ID=27508376
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK475389A DK475389A (da) | 1988-09-28 | 1989-09-27 | Fremgangsmaade til reduktion af monoklonale antistoffers heterogenitet |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0361902B1 (da) |
JP (1) | JP2925181B2 (da) |
CN (1) | CN1041392A (da) |
AR (1) | AR242986A1 (da) |
AT (1) | ATE101876T1 (da) |
AU (1) | AU615576B2 (da) |
BG (1) | BG60017B2 (da) |
CA (1) | CA1332367C (da) |
DE (1) | DE68913251T2 (da) |
DK (1) | DK475389A (da) |
ES (1) | ES2049332T3 (da) |
IE (1) | IE63562B1 (da) |
IL (1) | IL91778A (da) |
MX (1) | MX170441B (da) |
NZ (1) | NZ230786A (da) |
PL (1) | PL162260B1 (da) |
RO (1) | RO105652B1 (da) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2006381B1 (en) | 2006-03-31 | 2016-02-03 | Chugai Seiyaku Kabushiki Kaisha | Method for controlling blood pharmacokinetics of antibodies |
EP1878747A1 (en) | 2006-07-11 | 2008-01-16 | greenovation Biotech GmbH | Glyco-engineered antibodies |
EP2031064A1 (de) * | 2007-08-29 | 2009-03-04 | Boehringer Ingelheim Pharma GmbH & Co. KG | Verfahren zur Steigerung von Proteintitern |
SG193868A1 (en) | 2007-09-26 | 2013-10-30 | Chugai Pharmaceutical Co Ltd | Modified antibody constant region |
PL2202245T3 (pl) | 2007-09-26 | 2017-02-28 | Chugai Seiyaku Kabushiki Kaisha | Sposób modyfikowania punktu izoelektrycznego przeciwciała poprzez podstawienie aminokwasu w cdr |
ES2563483T3 (es) | 2008-04-11 | 2016-03-15 | Chugai Seiyaku Kabushiki Kaisha | Molécula de unión a antígeno capaz de unirse repetidamente a dos o más moléculas de antígeno |
TWI440469B (zh) * | 2008-09-26 | 2014-06-11 | Chugai Pharmaceutical Co Ltd | Improved antibody molecules |
JP5717624B2 (ja) | 2009-03-19 | 2015-05-13 | 中外製薬株式会社 | 抗体定常領域改変体 |
EP2826789A1 (en) | 2009-03-19 | 2015-01-21 | Chugai Seiyaku Kabushiki Kaisha | Antibody constant region variant |
US20140234340A1 (en) | 2010-11-30 | 2014-08-21 | Chugai Seiyaku Kabushiki Kaisha | Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly |
SG191371A1 (en) * | 2010-12-28 | 2013-08-30 | Chugai Pharmaceutical Co Ltd | Animal cell culturing method |
RU2662991C2 (ru) * | 2013-03-12 | 2018-07-31 | Биокон Лтд. | Слитые иммуномодулирующие белки и способы их получения |
US10782290B2 (en) | 2013-06-11 | 2020-09-22 | National Center Of Neurology And Psychiatry | Method for predicting post-therapy prognosis of relapsing-remitting multiple sclerosis (RRMS) patient, and method for determining applicability of novel therapy |
AU2016224409B2 (en) | 2015-02-27 | 2021-01-28 | Chugai Seiyaku Kabushiki Kaisha | Composition for treating IL-6-related diseases |
PL3299810T3 (pl) | 2015-05-19 | 2021-12-13 | National Center Of Neurology And Psychiatry | Sposób określania zastosowania nowej terapii u pacjentów ze stwardnieniem rozsianym (sm) |
ES2876416T3 (es) * | 2016-10-17 | 2021-11-12 | Enzene Biosciences Ltd | Procedimiento continuo para reducir la heterogeneidad de proteína terapéutica |
EP3620531A4 (en) | 2017-05-02 | 2021-03-17 | National Center of Neurology and Psychiatry | METHOD OF PREDICTION AND EVALUATION OF THERAPEUTIC EFFECT IN DISEASES RELATING TO IL-6 AND NEUTROPHILS |
KR20200074160A (ko) | 2017-10-20 | 2020-06-24 | 가꼬우호우징 효고 이카다이가쿠 | 항il-6 수용체 항체를 함유하는 수술 후의 유착을 억제하기 위한 의약 조성물 |
-
1989
- 1989-09-26 CA CA000613379A patent/CA1332367C/en not_active Expired - Fee Related
- 1989-09-26 AR AR89310004A patent/AR242986A1/es active
- 1989-09-26 BG BG89846A patent/BG60017B2/bg unknown
- 1989-09-26 NZ NZ230786A patent/NZ230786A/xx unknown
- 1989-09-26 RO RO141765A patent/RO105652B1/ro unknown
- 1989-09-26 IL IL9177889A patent/IL91778A/en not_active IP Right Cessation
- 1989-09-27 EP EP89309851A patent/EP0361902B1/en not_active Expired - Lifetime
- 1989-09-27 AU AU42343/89A patent/AU615576B2/en not_active Ceased
- 1989-09-27 DK DK475389A patent/DK475389A/da not_active Application Discontinuation
- 1989-09-27 IE IE309489A patent/IE63562B1/en not_active IP Right Cessation
- 1989-09-27 MX MX017721A patent/MX170441B/es unknown
- 1989-09-27 DE DE68913251T patent/DE68913251T2/de not_active Expired - Fee Related
- 1989-09-27 ES ES89309851T patent/ES2049332T3/es not_active Expired - Lifetime
- 1989-09-27 AT AT89309851T patent/ATE101876T1/de not_active IP Right Cessation
- 1989-09-27 PL PL89281598A patent/PL162260B1/pl unknown
- 1989-09-28 CN CN89107508.9A patent/CN1041392A/zh active Pending
- 1989-09-28 JP JP1256890A patent/JP2925181B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU4234389A (en) | 1990-04-05 |
MX170441B (es) | 1993-08-23 |
EP0361902A3 (en) | 1990-08-16 |
BG60017B2 (en) | 1993-06-30 |
CA1332367C (en) | 1994-10-11 |
CN1041392A (zh) | 1990-04-18 |
DK475389D0 (da) | 1989-09-27 |
JPH02163096A (ja) | 1990-06-22 |
IL91778A (en) | 1994-10-07 |
IE893094L (en) | 1990-03-28 |
AR242986A1 (es) | 1993-06-30 |
DE68913251T2 (de) | 1994-06-23 |
EP0361902A2 (en) | 1990-04-04 |
ATE101876T1 (de) | 1994-03-15 |
ES2049332T3 (es) | 1994-04-16 |
NZ230786A (en) | 1991-11-26 |
EP0361902B1 (en) | 1994-02-23 |
AU615576B2 (en) | 1991-10-03 |
RO105652B1 (ro) | 1992-11-30 |
PL162260B1 (pl) | 1993-09-30 |
DE68913251D1 (de) | 1994-03-31 |
IE63562B1 (en) | 1995-05-17 |
JP2925181B2 (ja) | 1999-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK475389A (da) | Fremgangsmaade til reduktion af monoklonale antistoffers heterogenitet | |
DK98584A (da) | Fremgangsmaade til detektering af aendret dna | |
ES531436A0 (es) | Procedimiento de obtener y aislar hibridomas secretores de anticuerpos, procedimiento de obtener anticuerpos y metodo de obtener polipeptidos | |
DK26587D0 (da) | Monoklonalt antistof, maalemetode for glucosyleret protein ved anvendelse af det monoklonale antistofog kit omfattende dette | |
DK610587D0 (da) | Analysemetode og -saet for antistof til hepatitis b-kerneantigen | |
ES546696A0 (es) | Procedimiento de preparar anticuerpos monoclonales y metodo de preparar reactivos para detectar canceres | |
DK14589A (da) | Fremgangsmaade til fremstilling af 1-alkyl-5-nitroimidazoler | |
DK409388A (da) | Fremgangsmaade til reduktion af ketoner | |
DK717888D0 (da) | Monoklonale antistoffer | |
DK437087A (da) | Monoklont antistof til bestemmelse af humant glycoalbumin | |
DK144485A (da) | Monoklonale antistoffer | |
DK447685D0 (da) | Fremgangsmaade til fremstilling af mel med hoej proteinkvalitet | |
DK147885D0 (da) | Fremgangsmaade til fremstilling af glycosidbindingrelateret antigen | |
DK0401657T3 (da) | Fremgangsmåde til C-terminal modificering af proteiner | |
DK276185D0 (da) | Monoklonale antistoffer,fremgangsmaade til fremstilling af disse samt deres diagnostiske anvendelse | |
DK134487A (da) | Monoklonalt antistof med affinitet for humant interleukin-2 | |
DK24891D0 (da) | Monoklonalt antistof til inhibering af cellers infektion med hiv-vira | |
DK413389A (da) | Monoklonale antistoffer | |
DK338889A (da) | Fremgangsmaade til bestemmelse af antistoffer | |
DK182084A (da) | Fremgangsmaade til fremstilling af 2-alkyl-4-amino-5-aminomethylpyrimidin | |
DK49585D0 (da) | Fremgangsmaade til paavirkning af laeskehastigheden for braendt kalk og anvendelse af fremgangsmaaden | |
DK240286A (da) | Monoklonale antistoffer | |
ZA897324B (en) | Method for the reduction of heterogeneity of monoclonal antibodies | |
DK143389A (da) | Fremgangsmaade til fremstilling af 20-deoxotylosin | |
DK630886A (da) | Monoklonalt antistof mod human pancreas-amylase, fremgangsmaade til fremstilling deraf og fremgangsmaade til bestemmelse af human pancreas-amylase ved hjaelp af antistoffet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHS | Application shelved for other reasons than non-payment |